Prognostic significance of cellular vascular endothelial growth factor (vegf) expression in the course of chronic myeloid leukaemia

Srpski Arhiv Za Celokupno Lekarstvo

Volumn 137, Issue 7-8, 2009, Pages 379-383

  Vidović, Ana ^a   Janković, Gradimir ^a   Tomin, Dragica ^a   Peruničić Jovanović, Maja ^a   Djunić, Irena ^a   Djurašinović, Vladislava ^a   Čolović, Milica ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Chronic myeloid leukaemia; Prognosis; VEGF

Indexed keywords

VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 70449560976     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH0908379V     Document Type: Article

References (21)

1. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. Chronic myelogenous leukemia. A concise update. Blood. 1993; 82:691-703.
2. Kantarjian HM, Keating MJ, Talpaz M, et al. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med. 1987; 83:445-54.
3. Kantarjian HM, Talpaz M. Definition of the accelerated phase of chronic myelogenous leukemia. J Clin Oncol. 1988; 6:180-1.
4. Aguayo A, Estey E, Kantarjian H, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood. 1999; 94(11):3713-21.
5. Aguayo A, Kantarjian H, Manshouki T, et al. Angiogenesis in acute chronic leukemias and myelodysplastic syndromes. Blood. 2000; 96(6):2240-5.
6. Di Raimondo F, Palumbo GA, Molica S, Giustolisi R. Angiogenesis in chronic myeloproliferative disease. Acta Haematologica. 2001; 106(4):177-83.
7. Vertovsek S, Kantarjian H, Manshouri T, et al. Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase of chronic myeloid leukemia. Blood. 2002; 99(6):2265-7.
8. Legros L, Bourcier C, Jacquel A, et al. Imatinib mesyalate (STI571) decrease the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia. Blood. 2004; 104(2):495-501.
9. Ratajczak MZ, Ratajczak J, Machalinski B, et al. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PIGF) in regulating human haemopoietic cell growth. Br J Haematol. 1998; 103:969-79.
10. Canellos G. Diagnosis and treatment of chronic granulocytic leukemia. In: Wiernik PH, Canellos GP, Kyle RA, et al, editors. Neoplastic Disease of the Blood. New York: Churchill Livingstone; 1991. p.61-76.
11. Cervantes F, Hernandez-Boluda JC, Ferrer A, Cid J, Montserrat E. The changing profile of Ph-positive chronic myeloid leukemia at presentation: possible impact of erlier diagnosis on survival. Haematologica. 1999; 84:324-7.
12. Cervantes F, Lopez-Gruillermo A, Bosch F, et al. An assessment of the clinico-hematological criteria for the accelerated phase of chronic myeloid leukemia. Eur J Hematol. 1996; 57:286-91.
13. Benett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the report of the French-American-British Cooperative Group. Ann Intern Med. 1985; 103:620-9.
14. Brunning RD, Matutes E, Haris NL, et al. Acute myeloid leukemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organisation (WHO) classification of tumors. Pathology and genetics of tumours of hematoietic and lymphoid tissues. Lyon: IARC Press; 2001. p.75-109.
15. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organisation classification of hematological malignacies. Report of the clinical advisory committee meeting. Airlie House, Virginia, November 1997. Mod Pathol. 2000; 13:193-207.
16. Scott CS, Der Ottolander GK, Swisky D, et al for International Council for Standardisation in Haematology (ICSN). Recommended procedures for the classification of acute leukemias. Leukemia Lymphoma. 1993; 11:37-50.
17. Parez-Atayde AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997; 150:815.
18. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogensis in patients with acute myeloid leukemia. Blood. 2000; 95:309.
19. Pruneri G, Bertolini F, Soligo D, et al. Angiogenesis in myelodysplastic syndromes. Br J Cancer. 1999; 81:1398.
20. Vidović A, Janković G, Čolović M, et al. The proto-oncogene expression varies over the course of chronic myeloid leukemia. Hematol. 2008; 13:34.
21. Calabretta B, Perrotti D. The biology of CML blast crisis. Blood. 2004; 103:4010.